Hostname: page-component-7dd5485656-c8zdz Total loading time: 0 Render date: 2025-10-31T03:16:27.932Z Has data issue: false hasContentIssue false
  • English
  • Français

Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters

Published online by Cambridge University Press:  18 November 2004

RAVENDRA GARG ,
NIRPENDRA SINGH  and
ANURADHA DUBE
RAVENDRA GARG
Affiliation:
Division of Parasitology, Central Drug Research Institute, PO Box 173, Lucknow – 226001, India
NIRPENDRA SINGH
Affiliation:
Division of Parasitology, Central Drug Research Institute, PO Box 173, Lucknow – 226001, India
ANURADHA DUBE
Affiliation:
Division of Parasitology, Central Drug Research Institute, PO Box 173, Lucknow – 226001, India
Get access Rights & Permissions [Opens in a new window]

Abstract

The role of the essential nutrients, vitamins A,B (complex), C and E and iron, as prophylactic as well as supportive therapy in experimental visceral leishmaniasis (VL), was studied in hamsters. Prophylactic administration of vitamin C (50, 100 and 250 mg/kg) from day15 to day 0 (15 doses) significantly reduced the intake of Leishmania donovani in hamsters but had no therapeutic effect. In contrast, vitamins A,B complex and E and iron, whether used prophylactically or therapeutically, promoted parasite multiplication. The efficacy of sodium stibogluconate, a reference antileishmanial drug, was appreciably improved in animals administered prophylactically with vitamin C. However, supplementation of vitamin C during established infections resulted in reduced drug action. The results show that the prophylactic use of vitamin C may prevent the onset of leishmania infection and cautions against the indiscriminate use of nutrient supplements such as vitamin A, B complex, and E and iron in VL endemic areas.

Keywords

Leishmania donovanihamstervitamin Avitamin B complexvitamin Cvitamin Eironsodium stibogluconate

Information

Type
Research Article
Information
Parasitology , Volume 129 , Issue 6 , December 2004 , pp. 685 - 691
Copyright
© 2004 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

ADINOFLI, L. E., BONVENTRE, P. F., PAS, M. V. & EPPSTEIN, D. A. ( 1985). Synergistic effects of glucantime and liposome encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infection and Immunity 48, 409–416.Google Scholar
ANDERSON, R. ( 1981). Ascorbic acid and immune functions. Mechanism of immunostimulation. In Vitamin C Ascorbic Acid (ed. Counsell, J. N. & Hornig, D. H.), p. 249. Applied Science Publication, London.
ANSTEAD, G. M., CHANDRASEKAR, B., ZHAO, W., YANG, J., PEREZ, L. & MELBY, P. C. ( 2001). Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infection and Immunity 69, 4709–4718.CrossRefGoogle Scholar
BEHARKA, A., REDICAN, S., LEKA, L. & MEYDANI, S. N. ( 1997). Vitamin E status and immune function. Methods in Enzymology 282, 247–263.CrossRefGoogle Scholar
BENDICH, A. & COHEN, M. ( 1988). B vitamins: effect on specific and nonspecific immune responses. In Nutrition and Immunology ( ed. Liss, A. R.), pp. 101–123. New York.
BHASKARAN, P. ( 1988). Immunology of iron deficient subjects. In Nutrition and Immunology ( ed. Liss, A. R.), pp. 149–168. New York.
BRESEE, J. S., FISCHER, M., DOWELL, S. F., JOHNSTON, B. D., BIGGS, V. M., LEVINE, R. S., LINGAPPA, J. R., KEYSERLING, H. L., PETERSEN, K. M., BAK, J. R., GARY, H. E. Jr., SOWELL, A. L., RUBENS, C. E. & ANDERSON, L. J. ( 1996). Vitamin A therapy for children with respiratory syncytial virus infection; a multicenter trial in the United States. Pediatric Infectious Disease Journal 15, 777–782.CrossRefGoogle Scholar
BUCHMULLER-ROUILLER, Y. & MAUEL, J. ( 1987). Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania species. Infection Immunity 55, 587–593.Google Scholar
CALDER, P. C. ( 2001). Nutrition et fonction immunitaire. Nutrition and Clinical Metabolism 15, 286–297.CrossRefGoogle Scholar
CARVALHO, E. M., BADARO, R., REED, S., JONES, T. C. & JOHNSON, W. D. ( 1985 a). Absence of gamma-interferon and interleukin-2 production during active visceral leishmaniasis. Journal of Clinical Investigation 76, 2066–2069.Google Scholar
CARVALHO, E. M., JOHNSON, W. B., BARRETO, E., MARSDEN, P. D., COSTA, J. L. M., REED, S. & ROCHA, S. ( 1985 b). Cell immunity in American cutaneous and mucosal leishmaniasis. Journal of Immunology 135, 4144–4148.Google Scholar
CERF, B. J., JONES, T. C., BADARO, R., SAMPAIO, D., TEIXEIRA, W. D. & JOHNSON, W. J. Jr. ( 1987). Malnutrition as a risk factor for severe visceral leishmaniasis. Journal of Infectious Diseases 4156, 1030–1033.CrossRefGoogle Scholar
CHATTERJEE, G. C. ( 1967). Ascorbic acid requirements of microorganism. In The Vitamins- Chemistry, Physiology, Pathology, Methods (ed. Serbrell, W. H. Jr. & Harris, R. S.), Vol. I, 2nd Edn, pp. 490–491. Academic Press, London.
CILLARI, E., DIELI, M., LOCOMPO, P., SIRECI, G., CAFFARELI, A., MALTESE, E., MILLOTT, S., MILANO, S. & LIEW, F. Y. ( 1991). Protective effect of isoprinosine in genetically susceptible Balb/c mice infected with Leishmania major. Immunology 74, 25–30.Google Scholar
CILLARI, E., LIEW, F. Y., LOCOMPO, P., MILANO, S., MENSUETO, S. & SALERNO, A. ( 1988). Suppression of IL-12 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis. Journal of Immunology 140, 2721–2726.Google Scholar
DOENHOFF, M. J., MODHA, J., LAMBERTUCCI, J. R. & McLAREN, D. J. ( 1991). The immune dependence of chemotherapy. Parasitology Today 7, 16–18.CrossRefGoogle Scholar
DUBE, A., SHARMA, P., SRIVASTAVA, J. K., MISRA, A., NAIK, S. & KATIYAR, J. C. ( 1998). Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG. Parasitology 116, 219–221.Google Scholar
FAWZI, W. W., MBISE, R. & SPIEGELMAN, D. ( 2000). Vitamin A supplements and diarrhea and respiratory tract infections among children in Dar es Salaam, Tanzania. Journal of Pediatrics 137, 660–667.CrossRefGoogle Scholar
FRANKENBURG, S., WANG, XIN & MILNER, Y. ( 1998). Vitamin A inhibits cytokines produced by Type 1 lymphocytes in vitro. Cellular Immunology 185, 75–81.CrossRefGoogle Scholar
FREIREICH, E. J., GEHAN, E. A., RALL, D. P., SCHMIDT, L. H. & SKIPPER, H. E. ( 1966). Quantitative comparison of toxicity of anti-cancer agents in mouse, rat, dog, monkey and men. Cancer Chemotherapy Reports 50, 219–244.Google Scholar
GEBER, W. F., LEFKOWITZ, S. S. & HUNG, C. Y. ( 1975). Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Pharmacology 13, 228–233.CrossRefGoogle Scholar
GHOSE, A. C., HALDAR, J. P., PAL, S. C., MISHRA, B. R. & MISHRA, K. K. ( 1979). Phytohaemagglutinin induced lymphocyte transformation test in Indian Kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 725–726.CrossRefGoogle Scholar
GIRODON, F., LOBARD, M. & GALAN, P. ( 1997). Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Annals of Nutritional Metabolism 41, 98–107.CrossRefGoogle Scholar
GLASZIOU, P. P. & MACKERRAS, D. E. M. ( 1993). Vitamin A supplementation in infectious diseases: a meta-analysis. British Medical Journal 306, 366–370.CrossRefGoogle Scholar
HAIDARIS, C. G. & BONVENTRE, P. F. ( 1983). Efficacy of combined immunostimulation and chemotherapy in experimental visceral leishmaniasis. American Journal of Tropical Medicine and Hygeine 32, 286–295.CrossRefGoogle Scholar
HALDAR, J. P., GHOSE, S., SAHA, K. C. & GHOSE, A. C. ( 1983). Cell mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis. Infection and Immunity 42, 702–707.Google Scholar
HAN, S. N., WU, D. & HA, W. K. ( 2000). Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology 100, 487–493.CrossRefGoogle Scholar
HAYEK, M. G., TAYLOR, S. F. & BENDER, B. S. ( 1997). Vitamin E supplementation decreases lung virus titers in mice infected with influenza. Journal of Infectious Diseases 176, 273–276.CrossRefGoogle Scholar
HO, M., KOECH, D. K., IHA, D. W. & BRYCESON, A. D. M. ( 1983). Immunosuppression in Kenyan visceral leishmaniasis. Clinical and Experimental Immunology 51, 207–214.Google Scholar
HOWARD, J. G. & LIEW, F. Y. ( 1984). Mechanisms of acquired immunity in leishamaniasis. Philosophical Transactions of the Royal Society of London, Series B 307, 87–98.CrossRefGoogle Scholar
KATIYAR, J. C., MISRA, A. & VISEN, P. K. S. ( 1986). Role of host immunity on the efficacy of thiabendazole in rats infected with Nippostrongylus brasiliensis. Wiadomosci Parazytologiczne/Parasitological News TXXX11 NR2, 163–172.Google Scholar
KJOLHEDE, C. L., CHEW, F. J. & GADOMSKI, A. M. ( 1995). Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. Journal of Pediatrics 126, 807–812.CrossRefGoogle Scholar
LEIBOVITZ, B. & SIEGEL, D. V. ( 1978). Ascorbic acid, neutrophil function and the immune response. International Journal for Vitamin and Nutrition Research 48, 159–164.Google Scholar
LESOURD, B. M., MAZARI, L. & FERRY, M. ( 1998). The role of nutrition in immunity on the aged. Nutritional Reviews 56, S113–S125.CrossRefGoogle Scholar
MELBY, P. C., TRYON, V. V., CHANDRASEKAR, B. & FREEMAN, G. L. ( 1998). Cloning of syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infection and Immunity 66, 2135–2142.Google Scholar
MISRA, A., KATIYAR, J. C. & SEN, A. B. ( 1980). Experimental studies with Nippostrongylus brasiliensis on factors modifying therapeutic efficacy of anthelmintics in rat. Indian Society of Experimental Biology 18, 906–909.Google Scholar
MOORE, K. J., LABRECQUE, S. & MATLASHEWSKI, G. ( 1993). Alteration of Leishmania donovani infection level by selective impairment of macrophage signal transduction. Journal of Immunology 150, 4457–4465.Google Scholar
MURPHY, S., WEST, K. P. Jr., GREENOUGH, W. B., CHEROT, E., KATZ, J. & CELEMENT, L. ( 1992). Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age and Ageing 21, 435–439.CrossRefGoogle Scholar
OPPENHEIIMER, S. J. ( 1989). Iron and malaria. Parasitology Today 5, 77–79.CrossRefGoogle Scholar
PAL, R., ANURADHA, GURU, P. Y. & KATIYAR, J. C. ( 1989). Leishmania donovani in hamster: escape of amastigotes to unusual sites following drug therapy. Medical Science Research 17, 579–581.Google Scholar
PAL, R., ANURADHA, RIZVI, S. Y., KUNDU, B., MATHUR, K. B. & KATIYAR, J. C. ( 1991). Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptides and their impact on therapeutic efficacy. Experientia 15, 486–490.CrossRefGoogle Scholar
PINNOCK, C. B., DOUGLAS, R. M. & BADCOCK, N. R. ( 1986). Vitamin A status in children who are prone to respiratory tract infections. Australian Pediatric Journal 22, 95–99.CrossRefGoogle Scholar
QUINLAN, K. P. & HAYANI, K. C. ( 1996). Vitamin and respiratory syncytial virus infection: serum levels and supplementation trial. Archives of Pediatrics and Adolescent Medicine 150, 25–30.CrossRefGoogle Scholar
REINER, N. E. ( 1987). Parasite accessory cell interaction in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of macrophage interleukin 1 response by Leishmania donovani. Journal of Immunology 138, 1919–1925.Google Scholar
REINER, N. E., WINNIE, N. G., WILSON, C. B., CMASRE, W. R. & BURCHETT, S. K. ( 1990). Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Journal of Clinical Investigations 85, 1914–1924.CrossRefGoogle Scholar
REZAI, H. R., ARDEHALI, S. M., AMIRHAKIMI, G. & KHARAZMI, A. ( 1978). Immunological features of Kala-azar. American Journal of Tropical Medicine and Hygiene 27, 1079–1083.CrossRefGoogle Scholar
ROSS, A. C. ( 1998). Vitamin A supplementation as therapy-are the benefits disease specific? American Journal of Clinical Nutrition 68, 8–9.Google Scholar
SHARMA, P., ANURADHA, SHARAN, R., HAQ, W., KUNDU, B., KATIYAR, J. C. & MATHUR, K. B. ( 1996). Stimulation of non-specific resistance by human (-casein fragment (54–59)). and its synthetic analogues against Leishmania donovani infection. Protein and Peptide Letters 3, 261–266.Google Scholar
STEPHENSEN, C. B., FRANCHI, L. M. & HERNANDEZ, H. ( 1998). Adverse effects of high-dose vitamin A supplements in children hospitalized with pneumonia. Pediatrics 101, E3.CrossRefGoogle Scholar
TAIT, A. & SACKS, D. L. ( 1988). The cell biology of parasite invasion and survival. Parasitology Today 4, 228–234.CrossRefGoogle Scholar
THOMAS, W. R. & HOLT, P. G. ( 1978). Vitamin C and immunity – an assessment of the evidence. Clinical and Experimental Immunology 32, 370–379.Google Scholar
WALKER, G. H., BYNOE, M. L. & TYRRELL, D. A. J. ( 1967). Trial of ascorbic acid in prevention of colds. British Medical Journal 1, 603–606.CrossRefGoogle Scholar
WRIGHT, E. P. & EL AMIN, E. R. ( 1989). Leishmania infection: surfaces and immunity. Biochemical and Cellular Biology 67, 525–536.CrossRefGoogle Scholar
WYLER, D. J. ( 1982). Circulating factor from a kala-azar patient suppress in vitro antileishmanial T cell proliferation. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 304–306.CrossRefGoogle Scholar
WYLER, D. J., WEINBAUM, F. I. & HERROD, H. R. ( 1979). Characterization of in vitro proliferation responses of human lymphocytes to leishmanial antigens. Journal of Infectious Diseases 140, 215–221.CrossRefGoogle Scholar
ZEHRA, K., PAL, R., ANURADHA, RIZVI, S. Y., HAQ, W., KUNDU, B., KATIYAR, J. C. & MATHUR, K. B. ( 1995). Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy. Experientia 51, 725–730.CrossRefGoogle Scholar